Why the study?
Opioid prescribing for chronic pain has continued to rise worldwide despite mounting concerns over the associated risks of addiction and harm.
One in four adults in England are prescribed potentially dependence-forming medicines or antidepressants, often for long durations, necessitating improved clinical guidance, patient support, and shared decision-making.
Rising opioid prescribing despite known harms signals urgent need for intervention; leaves open optimal tapering strategies in chronic non-cancer pain.
Over the past 20 years, the use of opioid medicines for chronic pain has become increasingly controversial, with concerns mounting over the associated risks of addiction and harm. Despite this, opioid prescribing has continued to rise worldwide, reaching the point of a major public health crisis in some countries, including the United States[1]. While opioid […]
No takes yet. Share an insight, caveat, or question.
A 2022 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: